Derek Cole, PhD

Derek has over 20 years of medicinal chemistry and drug discovery experience. Prior to joining RayzeBio, he was Senior Director, Medicinal Chemistry for the GI-Drug Discovery Unit at Takeda, where he led a team of over 30 small molecule, peptide, oligonucleotide chemists and in vitro pharmacology, delivering both small molecule and peptide development candidates. 

Prior to Takeda, he held positions of increasing responsibility at Wyeth Pharmaceuticals and Pfizer, contributing to target validation, hit-to-lead and drug discovery in Neuroscience and Immunology. 

Derek earned his Ph.D. in Synthetic Chemistry at the University of Alberta, Canada. He is an inventor on multiple patents and has published and presented broadly on small molecule lead optimization and fragment based drug discovery. He co-organized the Fragment-based Lead Discovery conference in San Diego in 2018.